Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug2026-06-023%External coverage
FULC Stock Slumps Nearly 50% After Hours As FDA Kills Only Clinical Program Over Cancer Risk2026-06-0155%External coverage
Fulcrum Therapeutics Inc (FULC) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...2026-04-2823%External coverage
Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations2026-04-2723%External coverage
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20262026-04-2723%External coverage
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET2026-04-2023%External coverage